These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Corticosteroids in giant cell arteritis: primum nil nocere?].
    Author: Meola DC, Fierz A, Tschopp A, Landau K.
    Journal: Klin Monbl Augenheilkd; 2006 May; 223(5):379-81. PubMed ID: 16705509.
    Abstract:
    BACKGROUND: Steroids are the treatment of choice for giant cell arteritis but bear the risk of serious side effects. PATIENTS AND METHODS: We carried out a retrospective study on 34 patients with documented giant cell arteritis (24 with ocular involvement) by means of a questionnaire sent to the treating physicians. RESULTS: After a mean follow-up of 48 months, side effects occurred in 90 % of the patients. The most frequent were weight gain (> 50 %) and osteoporosis (> 40 %, F >> M). Side effects were more common in patients with ocular involvement and in women. Severe complications were significantly more frequent in patients with ocular involvement. CONCLUSIONS: Side effects are the rule and not the exception in the treatment of giant cell arteritis. They can affect quality of life. Physicians should bear them in mind as many are preventable and/or treatable.
    [Abstract] [Full Text] [Related] [New Search]